On July 22, the COVID-19 (Sars-Cov-2) Antigen Self Test Kit that independently developed by Anhui Deepblue Medical Technology Co., Ltd. obtained the CE1434 certificate. This is another breaking news and major innovation in Deepblue's anti-epidemic products after passing the British 3B phase test, the special self test authorization of BfarM in Germany, the special self test authorization of MINVWS in Netherlands, and the family self-test certificate of the Czech. Anhui Deepblue Medical Technology Co., Ltd. is the first company in Anhui Province and one of only ten domestic companies to obtain this certificate.
Since the global outbreak of pneumonia caused by the COVID-19 in 2020, Deepblue Medical integrating a large number of technical research and development capabilities independently developed 5 types of COVID-19 test kits including antibody, antigen, antigen+antibody, antigen + influenza A&B, and neutralizing antibody, which have completed product registration and obtained registration certificates in more than 60 countries overseas. Among them, the Deepblue COVID-19 antigen self-test kit was broadcast on German TV. With its superb product technology and excellent product quality, Deepblue Medical has developed rapidly in the global IVD industry, which has made Made in China, Made in Deepblue a good reputation in the international market.
In the future, Deepblue Medical will continue to work hard to cooperate with all countries in the world with high-quality products, preferential prices, efficient production capacity, faster speed and better services.